Expression of epidermal growth factor receptor (EGFR) in blood and tumor in patients with breast carcinoma: Prognostic analysis. (2021)
- Authors:
- Araujo, Rogerio Agenor de
- Monteiro, Maria Luíza Gonçalves dos Reis
- Bernardino Neto, Morun
- Silva, Marcelo José Barbosa
- Luz, Felipe Andrés Cordero da
- Marinho, Eduarda da Costa
- Nascimento, Camila Piqui
- Marques, Lara de Andrade
- Delfino, Patrícia Ferreira Ribeiro
- Antonioli, Rafael Mathias
- Araújo, Breno Jeha
- Silva, Ana Cristina Araújo Lemos da
- Araujo, Rogerio Agenor de
- Autor USP: BERNARDINO NETO, MORUN - EEL
- Unidade: EEL
- DOI: 10.1200/jco.2021.39.15_suppl.e15013
- Assunto: ONCOLOGIA
- Language: Inglês
- Abstract: Background: EGFR acts on tumor progression and can be quantified in the blood (bEGFR) and in the tumor (tEGFR). This study analyzed the impact of these biomarkers on overall survival (OS) in different subtypes of breast carcinoma (BC). Methods: Prospective study with 214 patients with BC and 89 women with normal mammography and without a history of cancer (control), matched by age. All signed the free and informed consent form. Blood collection for bEGFR analysis, detected by the ELISA method using the R&D Systems DY231 kit, was performed before surgery (stages I and II; 80 patients), before neoadjuvant chemotherapy (CHT) (stages II and III; 103 patients) or before palliative CHT (stage IV; 31 patients). The material for analysis of tEGFR was from tumor biopsy, before any treatment, by immunohistochemistry using Dako clone 31G7. Continuous Kaplan-Meier analysis and Cox regression were used for statistical tests. Statistical significance was established at p < 0.05. Results: At an average follow-up of 35.40 months (±15.65 months), 50 deaths occurred in an average time of 20.92 months (±11.80 months). The control group showed significantly higher bEGFR (p < 0.0005) [40.45 ng/ml (18.10 – 117.15 ng/ml)] than the BC group [29.90 ng/ml (4.78 – 100.85 ng/ml)]. There was no correlation between tEGFR and bEGFR (Spearman's rho of -0.022). There was no impact on OS (p = 0.518) according to the negativity (0%) or positivity (≥1%) of tEGFR. Tumors with negative estrogen receptor (ER), compared to positive ER, showed higher expression of tEGFR (p < 0.0001).No significant differences were found between high and low expression of bEGFR in patients Luminal A (n = 45; p = 0.588), Luminal B (n = 79; p = 0.742) or in positive HER2 (n = 38; p = 0.7520). Patients with Triple Negative BC (TN) (n = 46) and bEGFR ≤47.8 ng/ml had a higher OS [29.1 months (6.63 – 62.4)] than patients with bEGFR > 47.7 ng/ml [13.36 months (3.66 – 60.43), (p = 0.020)]. In multivariate analysis on TN tumors, covariated with the stage, an increased risk of death was demonstrated by about 330% [HR = 4.301 (1.476 – 12.538), p = 0.008] for patients with bEGFR > 47.8 ng/ml. In initial patients (I + II), covariate with the molecular subtype, an increased risk of death was demonstrated by about 420% [HR = 5,210 (1,237 – 21,948), p = 0.024] for bEGFR > 45.9 ng/ml. There was no significant correlation of bEGFR according to the histological grade of the tumor (G1, G2 or G3), the Ki67 (< or ≥14%) or body mass index. Conclusions: There was no correlation between bEGFR and tEGFR. Increased expression of bEGFR in patients with TN tumors is a significant predictor of lower SG. bEGFR was able to define patients with high and low risk of death in both initial and advanced TN tumors. The methodology for quantifying bEGFR expression is simple and inexpensive. In view of these findings, future studies should evaluate different therapeutic options according of the expression of this biomarker.
- Imprenta:
- Publisher: ASCO Publications
- Publisher place: Alexandria-VA
- Date published: 2021
- Source:
- Título: Journal of Clinical Oncology
- ISSN: 1527-7755
- Volume/Número/Paginação/Ano: v.39, n.15, p.e15013-e15013, 2021
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
ARAUJO, Rogerio Agenor de et al. Expression of epidermal growth factor receptor (EGFR) in blood and tumor in patients with breast carcinoma: Prognostic analysis. Journal of Clinical Oncology, v. 39, n. 15, p. e15013-e15013, 2021Tradução . . Disponível em: https://doi.org/10.1200/jco.2021.39.15_suppl.e15013. Acesso em: 09 jan. 2026. -
APA
Araujo, R. A. de, Monteiro, M. L. G. dos R., Bernardino Neto, M., Silva, M. J. B., Luz, F. A. C. da, Marinho, E. da C., et al. (2021). Expression of epidermal growth factor receptor (EGFR) in blood and tumor in patients with breast carcinoma: Prognostic analysis. Journal of Clinical Oncology, 39( 15), e15013-e15013. doi:10.1200/jco.2021.39.15_suppl.e15013 -
NLM
Araujo RA de, Monteiro MLG dos R, Bernardino Neto M, Silva MJB, Luz FAC da, Marinho E da C, Nascimento CP, Marques L de A, Delfino PFR, Antonioli RM, Araújo BJ, Silva ACAL da. Expression of epidermal growth factor receptor (EGFR) in blood and tumor in patients with breast carcinoma: Prognostic analysis. [Internet]. Journal of Clinical Oncology. 2021 ;39( 15): e15013-e15013.[citado 2026 jan. 09 ] Available from: https://doi.org/10.1200/jco.2021.39.15_suppl.e15013 -
Vancouver
Araujo RA de, Monteiro MLG dos R, Bernardino Neto M, Silva MJB, Luz FAC da, Marinho E da C, Nascimento CP, Marques L de A, Delfino PFR, Antonioli RM, Araújo BJ, Silva ACAL da. Expression of epidermal growth factor receptor (EGFR) in blood and tumor in patients with breast carcinoma: Prognostic analysis. [Internet]. Journal of Clinical Oncology. 2021 ;39( 15): e15013-e15013.[citado 2026 jan. 09 ] Available from: https://doi.org/10.1200/jco.2021.39.15_suppl.e15013 - Effects of acute and chronic exercise on the osmotic stability of erythrocyte membrane of competitive swimmers
- Influence of erythrocyte membrane stability in atherosclerosis
- EGF (epidermal growth factor) receptor expression in blood: Prognostic biomarker in overall survival (OS) of patients with non-metastatic triple negative (TN) breast carcinoma.
- Epidermal growth factor receptor (EGFR) expression in the serum of patients with triple-negative breast carcinoma: prognostic value of this biomarker
- The impact of coffee certification on production costs and price paid to the rural producers: a discussion from the viewpoint of transaction cost economics
- Decreased plasma iron levels in women with hyperglycemia are associated with inflammatory status and involve increased HbA1c, osmotic stability, and volume variability of red blood cells
- Oropharyngeal Colostrum Administration and Anti-inflammatory Effects in Very Low Birth Weight Preterm Neonates
- Saúde Mental, Uso de Álcool e Qualidade do Sono em Estudantes de uma Universidade Pública
- Aging profile, adherence to the Elderly Health Handbook and health self-perception, Ituiutaba-MG (2015 and 2018)
- Correlations of the glycemic variability with oxidative stress and erythrocytes membrane stability in patients with type 1 diabetes under intensive treatment
Informações sobre o DOI: 10.1200/jco.2021.39.15_suppl.e15013 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
